An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes - PubMed (original) (raw)
An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes
S Grimm et al. J Exp Med. 1997.
Free PMC article
Abstract
Apoptosis is a genetically programmed series of events that results in cell death. As a consequence, it is difficult to identify dominant genes that play a role in this process using genetic selections in conventional cell culture systems. Accordingly, we have established an efficient expression screen to isolate dominant, apoptosis-inducing genes. The assay is based on the apoptotic morphology induced in the human kidney cell line 293 after transient transfection of small plasmid pools from normalized cDNA expression libraries. Using this assay, we isolated a novel isoform of the proto-oncogene Neu differentiation factor (NDF), a ligand for erbB receptor tyrosine kinases. Several lines of experimental evidence indicate that this gene kills in a cell-autonomous fashion and independently of known erbB receptors. This apoptotic property of an NDF isoform is readily contrasted with NDF's transforming potential and might balance the tendency to tumorigenesis in cells that overexpress NDF.
Figures
Figure 1
Outline of the assay for cloning apoptosis-inducing genes. After normalization of the mRNA, a library was constructed in a mammalian expression vector. DNAs from pools of ∼20 bacteria clones were transiently transfected into 293 cells. The bacteria of the pool which induced morphological signs of apoptosis in cells (as indicated in the figure by a cell with altered shape) were plated and individual clone DNAs were once more transiently transfected. The positive clone was again identified by inspecting the cells for apoptosis induction.
Figure 2
Apoptosis induction by the isolated expression plasmid. 293 cells were transiently transfected with the empty vector (A) or the isolated plasmid clone (B). After 12 h, incubation phase contrast pictures at a 320-fold magnification were taken. (C) Expression of the isolated clone leads to DNA degradation. 293 cells were transfected with the vector (lane 1) or with the expression plasmid DNA (lane 2). After 16 h, low molecular weight DNA was isolated, separated on a 2% agarose gel, and stained with ethidium bromide.
Figure 4
Mapping of the apoptosis-inducing domains in β2b NDF with deletion mutants in BHK cells. The various domains are indicated on top of the diagrammatic representation of wild-type β2b NDF. IG, immunoglobulin domain; Glyco, glycosylated domain; EGF, epidermal growth factor homology domain; β, sequences of β exon; 2, sequences from exon 2; TM, transmembrane domain; Cyto, cytoplasmatic domain; b, sequences from exon b. The names of the deletion mutants indicate the deleted amino acids. Wild type or the deletion mutants of β2b NDF (4 μg) were transfected into BHK cells together with a marker plasmid (1 μg) for β-gal staining. 24 h after transfection the cells were stained with X-gal and the extent of apoptosis was measured by counting morphologically apoptotic, blue cells and determining their percentage of the total number of blue, transfected cells. Shown are the means and the standard deviation of a total of at least 1,000 counted cells from four independent experiments.
Figure 3
Expression profile of β2b NDF in mice as measured by RTPCR. β2b NDF-specific primers were used to amplify a 724-bp long DNA. The efficiency of the RT reaction was controlled by co-amplifying a 540-bp long β-actin fragment. Both products were detected by Southern blotting. The β2b NDF blot was exposed for 12 h, and the β-actin blot for 2 h.
Figure 5
Characterization of the apoptotic signal generated by β2b NDF. (A) Absence of NDF-binding erbB receptors in 293 cells as detected by RT-PCR. RNAs of the human mammary cell line MCF-7 and 293 cells were amplified, with or without earlier treatment with RT, with specific primers for the indicated genes. The PCR products were separated in agarose gels, blotted onto filters, and hybridized with gene-specific probes. β-actin was amplified to demonstrate the efficiency of the RT reactions. (B) Cells adjacent to NDF-transfected cells do not undergo apoptosis. BHK cells were transfected with the empty vector or β2b NDF (4 μg each) together with the marker plasmid for β-gal (1 μg), and apoptosis was monitored as in Fig. 4. Apoptosis was also measured in cells surrounding NDF-transfected, nonapoptotic (a) and apoptotic (b) cells. (C) β2b NDF-induced apoptosis is inhibitable by the ICE proteases inhibitor p35. BHK cells were transfected with β2b NDF (2 μg) and vector, CrmA, or p35 expression plasmids (2 μg). Apoptosis induction was measured as in Fig. 4.
Figure 5
Characterization of the apoptotic signal generated by β2b NDF. (A) Absence of NDF-binding erbB receptors in 293 cells as detected by RT-PCR. RNAs of the human mammary cell line MCF-7 and 293 cells were amplified, with or without earlier treatment with RT, with specific primers for the indicated genes. The PCR products were separated in agarose gels, blotted onto filters, and hybridized with gene-specific probes. β-actin was amplified to demonstrate the efficiency of the RT reactions. (B) Cells adjacent to NDF-transfected cells do not undergo apoptosis. BHK cells were transfected with the empty vector or β2b NDF (4 μg each) together with the marker plasmid for β-gal (1 μg), and apoptosis was monitored as in Fig. 4. Apoptosis was also measured in cells surrounding NDF-transfected, nonapoptotic (a) and apoptotic (b) cells. (C) β2b NDF-induced apoptosis is inhibitable by the ICE proteases inhibitor p35. BHK cells were transfected with β2b NDF (2 μg) and vector, CrmA, or p35 expression plasmids (2 μg). Apoptosis induction was measured as in Fig. 4.
Figure 5
Characterization of the apoptotic signal generated by β2b NDF. (A) Absence of NDF-binding erbB receptors in 293 cells as detected by RT-PCR. RNAs of the human mammary cell line MCF-7 and 293 cells were amplified, with or without earlier treatment with RT, with specific primers for the indicated genes. The PCR products were separated in agarose gels, blotted onto filters, and hybridized with gene-specific probes. β-actin was amplified to demonstrate the efficiency of the RT reactions. (B) Cells adjacent to NDF-transfected cells do not undergo apoptosis. BHK cells were transfected with the empty vector or β2b NDF (4 μg each) together with the marker plasmid for β-gal (1 μg), and apoptosis was monitored as in Fig. 4. Apoptosis was also measured in cells surrounding NDF-transfected, nonapoptotic (a) and apoptotic (b) cells. (C) β2b NDF-induced apoptosis is inhibitable by the ICE proteases inhibitor p35. BHK cells were transfected with β2b NDF (2 μg) and vector, CrmA, or p35 expression plasmids (2 μg). Apoptosis induction was measured as in Fig. 4.
Similar articles
- Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes.
Pinkas-Kramarski R, Eilam R, Spiegler O, Lavi S, Liu N, Chang D, Wen D, Schwartz M, Yarden Y. Pinkas-Kramarski R, et al. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9387-91. doi: 10.1073/pnas.91.20.9387. Proc Natl Acad Sci U S A. 1994. PMID: 7937775 Free PMC article. - Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo.
Grimm S, Weinstein EJ, Krane IM, Leder P. Grimm S, et al. J Exp Med. 1998 Oct 19;188(8):1535-9. doi: 10.1084/jem.188.8.1535. J Exp Med. 1998. PMID: 9782131 Free PMC article. - Structural and functional aspects of the multiplicity of Neu differentiation factors.
Wen D, Suggs SV, Karunagaran D, Liu N, Cupples RL, Luo Y, Janssen AM, Ben-Baruch N, Trollinger DB, Jacobsen VL, et al. Wen D, et al. Mol Cell Biol. 1994 Mar;14(3):1909-19. doi: 10.1128/mcb.14.3.1909-1919.1994. Mol Cell Biol. 1994. PMID: 7509448 Free PMC article. - The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS. Cooper CS. Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333. Environ Health Perspect. 1991. PMID: 1685444 Free PMC article. Review. - Neu and its ligands: from an oncogene to neural factors.
Peles E, Yarden Y. Peles E, et al. Bioessays. 1993 Dec;15(12):815-24. doi: 10.1002/bies.950151207. Bioessays. 1993. PMID: 7908191 Review.
Cited by
- Neuregulin-1, a potential therapeutic target for cardiac repair.
Wang Y, Wei J, Zhang P, Zhang X, Wang Y, Chen W, Zhao Y, Cui X. Wang Y, et al. Front Pharmacol. 2022 Aug 31;13:945206. doi: 10.3389/fphar.2022.945206. eCollection 2022. Front Pharmacol. 2022. PMID: 36120374 Free PMC article. Review. - Determining signalling nodes for apoptosis by a genetic high-throughput screen.
Lin B, Huntley D, Abuali G, Langley SR, Sindelar G, Petretto E, Butcher S, Grimm S. Lin B, et al. PLoS One. 2011;6(9):e25023. doi: 10.1371/journal.pone.0025023. Epub 2011 Sep 22. PLoS One. 2011. PMID: 21966401 Free PMC article. - EGFs and ERBBs--brief history and prospects.
Stern DF. Stern DF. Semin Cell Dev Biol. 2010 Dec;21(9):917-21. doi: 10.1016/j.semcdb.2010.10.006. Epub 2010 Oct 21. Semin Cell Dev Biol. 2010. PMID: 20970513 Free PMC article. - The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
Chua YL, Ito Y, Pole JC, Newman S, Chin SF, Stein RC, Ellis IO, Caldas C, O'Hare MJ, Murrell A, Edwards PA. Chua YL, et al. Oncogene. 2009 Nov 19;28(46):4041-52. doi: 10.1038/onc.2009.259. Epub 2009 Oct 5. Oncogene. 2009. PMID: 19802002 Free PMC article. - Roles for neuregulins in human cancer.
Stove C, Bracke M. Stove C, et al. Clin Exp Metastasis. 2004;21(8):665-84. doi: 10.1007/s10585-004-6917-6. Clin Exp Metastasis. 2004. PMID: 16035612 Review.
References
- Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol. 1991;7:663–698. - PubMed
- Steller H, Grether ME. Programmed cell death in Drosophila. . Neuron. 1994;13:1269–1274. - PubMed
- Vito P, Lucana E, D'Adamio L. Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science (Wash DC) 1996;271:521–525. - PubMed
- Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM. Bcl-x and Bcl-2 inhibit TNF and Fas- induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene. 1995;10:2297–2305. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous